Trials / Completed
CompletedNCT01004237
Additive Effects of Pravastatin and Valsartan
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 52 (actual)
- Sponsor
- Gachon University Gil Medical Center · Academic / Other
- Sex
- All
- Age
- 25 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The investigators hypothesize that pravastatin combined with valsartan may have additive effects in hypertensive, hypercholesterolemic patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | pravastatin, valsartan, pravastatin+valsartan | pravastatin 40 mg, valsartan 160 mg 8 weeks of treatment |
Timeline
- Start date
- 2009-11-01
- Primary completion
- 2012-04-01
- Completion
- 2012-04-01
- First posted
- 2009-10-29
- Last updated
- 2012-08-09
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01004237. Inclusion in this directory is not an endorsement.